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PURPOSE
The purpose of this investigation will be to study the
pharmacology of the polyamine spermidine in further detail.
The general pharmacology, including acute toxicity, in vitro
bioassay and in vivo physiologic responses will be described.
The variability of the toxicity of spermidine during a programmed
light-dark cycle will be studied.

A possible interaction between

spermidine and histamine will be studied in relation to the daily
fluctuation of their levels in the central nervous system as well
as their effect on pentobarbital-induced sleeping time.

,

.

INTRODUCTION
HISTORY,DEFINITION AND CHEMISTRY
The polyamines are a diverse group of nitrogenous bases widely
distributed throughout nature. They include aliphatic , heterocyclic
and aromatic derivatives but most recent interest has centered on a
series of aliphatic di- and polyamines. The structures of the major
members of this group are seen in Table I .
Antoni Van Leeuwenhoek is credited with the recognition of
crystais of spermine in samples of human semen ( Leeuwenhoek ,
A. Van,l678 ; Smith,T.A. , 1972 ). It was not until well over two
hundred years later however that the correct structure of spermine
was established and its synthesis accomplished ( Dudley,H.W. et al.,
1926 ).

/
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THE
NH2(CH2)3NH2
NH2(CH2)4NH2

~1AJOR

POLYM1INES

..........................
..........................

1,3- diaminopropane

..........................

1,5- diaminopentane
(cadaverine)

1,4- diaminobutane
(putrescine)

NH2(CHz)3NH(CH2)4NH2 ••..........••.... spermidine

TABLE I

/
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OCCURRENCE IN BIOLOGIAL MATERIAL
PLANTS
There has been relatively little interest in the presence and
possible role of polyamines in plant material (Smith, T.A., 1972).
Putrescine is the major member of the series found in most plant
species (Smith,T.A., 1970). Spermidine and spermine are also present
in most higher plants in quantities ranging from 0.01 - 0.25
micromoles per gram (Smith, T.A., 1970). These compounds are predominantly found in the leaves of these plants and in the embryo of the seed,
particularly during earlier stages of germination.
BACTERIA AND VIRUSES
Polyamines are found in relatively high concentration in T-even
bacteriophages of E. coli (Ames et al., 1958). They are present in
concentrations which can neutralize up to forty percent of the DNA
phosphorus of the virus.

Unlike many strains of bacteria, the

bacteriophage does not take up polyamines from the medium and thus
their presence in these organisms represents the best evidence
for the in vivo associ at ion of the polyamines and nucleic acids.

4

Spermidine and trace quantities of spermine have been identified
as constituents of Turnip Yellow Mosaic virus (TYMV).
<

:.

The total
io.

amount found would be sufficient to neutralize approximately twenty
percent of the viral RNA (Beer,

·s.v.

and Kosuge, T., 1970).

Polyamines are found in a variety of bacteria, yeasts and fungi
(Tabor, H. and

Tabor~

C.W., 1972). Their

concentra~ion

in bacteria

is in part dependent on the characteristics of the medium used and
the conditions of growth present.

Higher concentrations are found

when organisms are grown in a medium enriched with polyamines.

The

mechanisms of uptake of polyamines by E. coli have been

by

studi~d

Tabor and Tabor (1966). They described (a) a non-energy dependent
adsorption of amines onto the cell surface and (b) an energy-dependent
uptake, stimuiated by

glucose~

into the interior of the cell.

Higher

concent.rations of polyamines are also found during periods of growth
of bacterial cultures.

Gram-negative bacteria contain large amounts

of polyamines· while gram-positives contain relatively little or none
at all (Herbst et al., 1958).
Significant quantities of polyamines are found in the fungus
Neurospora crassa.

A magnesium deficient medium can stimulate polyamine

synthesis in this orgnaism (Viotti, A., et al., 1971).

/
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ANIMALS
The highest concentrations of spermidine and spermine in animal
tissues.are found in pancreas, prostate and human semen (Rosenthal, S.M.
and Tabor, C.W., 1956; Tabor, H. and Tabor, C.W., 1964). The high
concentration of spermine in human semen forms the basis for some
medicolegal studies.

Table II summarizes the reported levels of

spermidine and spermine in selected animal tissues.
Pfeiffer et al. (1970) and Iliev et al. (1968) have studied
polyamine levels in whole blood of humans.

Levels of spermidine were

detectable in the range of 0.9 to l.Omg./ml. and the concentration
·,

of spermine was 1.38 to 1.48 mg./ml.

·'

They found no correlation with

the age or sex of the subjects.
The molar ratio of spermidine to spermine varies with the
tissue and its stage of development (see below) but in general the
ratio is between 1.0 and 2.0 except in the case of testes, kidney,
skeletal muscle and human semen and prostate, where the ratio is
less than one in most species.

Janne et al. (1964) have shown in

the rat that levels of spermidine decrease significantly after birth
in all

6

THE CONCENTRATION OF POLYAMINES IN SELECTED
ANIMAL TISSUES
ANIMAL SOURCE

SPERMIDINE
( ug/gm )

SPERMINE
{ug/gm}

Semen

Human

trace

3300

Prostate

Human
Rat

1122

495
1155

Liver

Human
Rat
Mouse

230
235

495
235
155

Spieen

Human
Rat

230

45
134

Bone Marrow

Human

Pancreas

Rat
Mouse
Guinea pig

ORGAN

Testis

Rat

148
1250
410
312

194
202
280

55

105

TABLE II

/
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tissues examined while spermine shows relatively little change except
in the case of brain and skeletal muscle.

Thus, the molar ratio of

the two decreases over the first few months of life.
By radioautography, Dion and Herbst (1967) have shown a
localization of spermidine within the nucleus of the salivary gland
of Drosophila melanoqaster.

Application of this technique to the

intracellular localization of polyamines in other systems has not been
successful.
The presence of spermidine and spermine in neural tissue was
unappreciated until Kremzer {1966) and Michaelson (1967) identified
them as contaminants in the existing method for the detection of
histamine.

That method, described by Shore, Burkhalter and Cohn in

i959, involved the n-butanol extraction of alkalinized perchloric
acid tissue extracts which were then condensed with o-pthaldialdehyde
(OPT) to form a fluorescent product.

(Histamine and spermidine have

very similar fluorescence spectra when complexed with OPT.
are maximally activated at 350 mu.)
spermidine at 400 mu.

Both

Histamine is read at 450 mu and

Using this method Michaelson and Dowe (1963)

had reported histamine levels of 2.2 nanomoles per gram of guinea pig
brain.

Carlini and Green (1963) reported similar levels of 2.2 nanomoles

per- gram using the same method but found only 0.48 nanomoles per gram

/
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when a biological assay {guinea

pi~

ileum) was used.

In a study

of the diurnal variability of histamine levels in rat caudate nucleus,
Friedman and Walker (1968) reported histamine levels ranging from
10.5 to 20.1 nanomoles per gram.

Eliminating spermidine and spermine

using the method of Anton and Sayre (1968) the true levels of
histamine were subsequently found to vary between 0.63 and 1.08
nanomoles per gram (Friedman, A.H. and Walker, C.A., 1969).

Thus~

spermidine and spermine were present in the rat caudate nucleus in a
concentration twenty times that of histamine.

The method of Kremzer

has subsequently been modified to separate histamine, spermidine
and spermine (Medina, M. and Short, P.A., 1966; Iliev, V. et al.,
1968; Hakanson, R., and Roonberg, A., 1973).

Michaelson has found the

phosphorylated cellulose resin used in the· latter methods unreliable
and has subsequently described the use of another phosphonic acid cation
exchange resin, Bio-Rex-63 (Bio-Rad Laboratories, Richmond, California)
which is more stable and consistent (Michaelson, I.A. and Coffman, P.A.,
(1969).

It is. the method of Mi chae 1son and Coffman that has been

modified for use in this study.

A highly sensitive and specific

enzymatic isotopic method for histamine has

subsequer:~tly

been devised

(Snyder, S.H., et al., 1966; Taylor, K.M. and Snyder, S.H., 1971;
Taylor, K.M. and Snyder, S.H., 1972).
obtained with this method.

Reference will be made to results

More recent methods for the detection of

9

polyamines have been described utilizing alternate cation exchange
resins (Marton et

al.~l973;

Tabor,H. and Tabor,C.W.,l973) or

gas chromatography (Denton,M.D. et al.,l973). Recently a method
has been developed for the detection of putrescine (Harik,S.I. et al.,
1973).
Significant levels of spermidine and spermine are present in
both the central and peripheral nervous systems. Reported concentrations have been variable, in part a function of the methodology
employed but perhaps also,as will be shown later in this study, a
function of the point in the light-dark cycle at which the tissues
were taken. Tables III and IV summarize levels reported in whole brain
homogenates of several species.
Despite their structural similarity and metabolic interrelationships, the regional distribution of spermidine and spermine are not
similar. Shaw and Pateman (1973) studied the levels of these amines
in selected brain areas of multiple species. In a thorough analysis
of sheep brain, highest levels of spermidine were detected in regions
rich in myelinated fiber tracts such as subcortical white matter
(115 ug/gm), cerebellar white matter (102ug/gm), pons (112ug/gm)
and optic chiasm (118 ug/gm}. Significantly lower levels were found
in neuronal masses such as cortical grey (25ug/gm), caudate nucleus
(24 ug/gm) and hypothalamus (37 ug/gm). Although absolute values

/
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REPORTED LEVELS ·oF SPERMIDINE IN WHOLE BRAIN
OF VARIOUS SPECIES

ANIMAL

WHOLE BRAIN
SPERMIDINE

REFERENCE

(ug/gm)

Guinea pig

35.2

Kremzer (1966)

Rabbit

45-48

Kremzer (1966)

62-71

Shimizu et a1. (1964)

65

Seiler (1973)

40

Shimizu et a1. (1965)

45

Giorgi et al. (1972)

98

Rosenthal and Tabor (1956)

44

Kremzer (1970)

70

Pearce and Schanberg (1969)

62

Seiler and Lamberty (1973)

House

Rat

Fish

TABLE Ill

i.
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REPORTED LEVELS OF

SPERt~INE

IN WHOLE BRAIN

OF VARIOUS SPECIES
ANIMAL

WHOLE BRAIN
SPERMINE
(ug/gm)

REFERENCE

Rabbit

29

Shimizu et a1. (1964)

Mouse

41

Giorgi et a1. (1972)

Rat

41

Tabor and Tabor (1964)

Fish

19

Sei 1er and· Lamberty ( 1973)

TABLE IV

·.

/
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varied somewhat, essentially similar distributions were found in rat,
rabbit, dog and human specimens. Cervical cord was studied in the
rat and rabbit and contained higher concentrations of spermidine than
any other area assayed. Studies of rat brain by Shimizu (1964)
showed a similar distribution and included analysis of peripheral
(sciatic) nerve which contained relatively low levels compared to areas
rich in central rather than peripheral myelin. Kremzer (1970) and
Kremzer et al.(l970) also analysed human brain with results similar
to those of Shaw and Pateman. In addition , no significant difference
was found in the spermidine concentration of different cortical areas.
(Cortical white matter contains considerably more spermidine, 92122ug/gm , than adjacent cortical ribbon, 20-38ug/gm.(Shaw and
Pateman,l973) ). The concentration of spermidine in rat caudate
nucleus was found to be 60ug/gm by Shimizu et al.(l964) while the
concentration of authentic histamine in this structure is 0.05-0.15
ug/gm (Friedman and Walker ,1969), explaining the spuriously high
levels of histamine reported when spermidine was not separated prior
to condensation with OPT.
Shaw and Pateman (1973) found less remarkable and less consistent
regional variability of spermine levels. In sheep brain , highest
levels were found in the pituitary,trigeminal nerve base, optic
chiasm, lateral geniculate bodies and the cerebral peduncles. Examination of two human brains shewed inconsistent levels but there was a

13
tendency toward high levels in more caudal brain areas, i.e. areas
of the brainstem. In rabbit brain Shimizu et al. (1964) found
highest levels of spermine in cortex and caudate nucleus (36ug/gm)
with a progressive decline in more caudal regions such as lumbar
spinal cord (9ug/gm) and sciatic nerve (5ug/gm). Kremzer et al.
(1970) did not find any significant difference in the spermine
concentration in several areas of sheep brain.
Neither Shaw and Pateman (1973) nor Kremzer et al. (1970)
could find detectable levels of spermidine or spermine in human
cerebrospinal fluid.

\

The absence of a reliable method for the determination of
putrescine has limited studies of this compound. Employing an
enzymatic-isotopic assay found to be both sensitive and specific,
Harik et al. (1973) have detected significant levels of putrescine
in mouse brain (0.17ug/gm) and rat brain (0. 17u§/gm).

I
f
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METABOLISM
SYNTHESIS
The biosynthesis of putrescine , spermidine and spermine has
been well characterized in microorganisms, particularly E. coli
(Bachrach, U., 1970; Tabor, H. and Tabor, C.W., 1972).

Studies

of animal tissue have included chick embryo (Raina, A., 1963), rat
liver, especially during regeneration (Janne, J., 1967; Slimes, M.,
1967; Russell, D.H. and Snyder, S.H., 1969; Snyder, S.H. and
Russell, D.H., 1970; Russell, D.H. and McVicker, T.A., 1971) and rat
prostate (Pegg, A.E., 1970; Pegg, A.E. and Williams-Ashman, H.G., 1970).
A review of preliminary studies of higher plants has recently been
presented by Smith (1970).
In all organisms studied the formation of spermidine involves
the addition of a propylamine group to 1,4-diaminobutane as seen in
Figure 1.

S-adenosylmethionine (SAMe) is perhaps most important in

biological systems as an active methyldonor (Baldessarini, R.J., and
Kopin, I.J., 1966). · Enzymes for its formation from ATP and methionine

15

FIGURE 1. BIOSYNTHESIS OF SPERMIDINE

cH3

coo-

'
I
SCH
2CH2CH NH2
1- methionine

yHs

9oo-

adenine- ribose -SCH2CH2CHNH2
S-adenosylmethi~nine (SAMe)

CH3
1.4-diamincbutane - - - - - a d e n i n e - ribose-SJCH 2CH2CH2NH2j

NJi:2CH2CH~H:2NHCH.2C~~H:2N~ + methylthioadenosine
spermidine

16
are present in most organisms.
as seen in the figure.

SAMe is decarboxyl ated enzymatically

In mammalian systems this enzyme is markedly

dependent on the presence of 1,4-diaminobutane (Pegg, A.E., and
Williams-Ashman, H.G., 1968).
in E.coli.

Mg++ is required for the enzyme found

A pyridoxal phosphate inhibitor, NSD-1055 inhibits the

mammalian enzyme but not the E. coli enzyme.

Recently, methylgloxal

Bis (guanylhydrazine) has been shown to be a specific competitive
inhibitor of SAMe decarboxylase (Williams-Ashman, H.G. and
Schenone, A., 1972; Pegg, A.E., 1973).
Propylamine transferase catalyses the last step in the formation
of spermidine.

The purified enzyme has no known cofactors.

Negative

feedback is exerted on its activity by the products of the reaction.
Although in some systems spermidine may act as a substrate of the same
enzyme (resulting in the formation of spermine), this is not the
case in mammalian systems (Janne, J. et al., 1971).

A second enzyme

for the formation of spermine from SAMe and spermidine has been purified
from both rat brain and regenerating rat liver (Hannonen, P. et al. 1971;
Hannonen, et al., (1972).
In the central nervous system, SAMe-Decarboxylase activity is
highest in the cerebral cortex and cerebellum (Snyder et al., 1973).
After intraventricular injection of labelled putrescine, these investigators

:1

.I

I.I
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found that virtually all of the putrescine had been converted to
spermidine and spermine by 48 hours.

Like tracer doses of other amines

such as tyrosine and histidine, 60 to 70% of the dose was converted within the first twenty minutes.

Overall, spermine accounted for

only 10 to 25% of the activity detected.

The tracer was initially

distributed to midbrain, hypothalamus and cerebellum but levels declined
sharply in these regions.

Spermidine activity was detected as early

as twenty minutes and reached peak levels in medulla-pons, internal
capsule and corpus striatum by 48 hours.

Activity in spermine could not

be detected until 48 hours and peak levels did not occur until the
fifteenth to nineteenth days, particularly in cerebral cortex and
cerebellum.
Kremzer et al. (1970) studied the regional distribution of
propylamine transferase activity in several regions of sheep brain.
Like SAMe decarboxylase activity and in contrast to the distribution of
ornithine decarboxylase, highest levels were found in the cerebral
cortex.
In animal tissue, ornithine is the only source of putrescine
for polyamine synthesis.

The conversion is catalysed by ornithine

decarboxylase, a specific enzyme found in most tissues.

It has been

purified from rat prostate (Janne, J. and Williams-Ashman, H.G., 1970)
and regenerating rat liver (Friedman, S.J., et al, 1972) and found to

18
require pyridoxal phosphate as a cofactor.

Its activity is stimulated

by its substrate but also by several hormones including testosterone
(rat prostate), hydrocortisone, growth hormone, ins~lfri, glucagon and
thyroxin (rat liver) and luteinizing hormone (rat ovary)(Russell, et al.,
1970; Pegg, A.E., et al, 1970; Panko, W.B. and Kenney, F.T., 1971;
Kobayaski, Y. et al, 1971).

Harik et al. (1974) have shown

alpha-hydrazino-ornithine to be a specific competitive inhibitor of the
enzyme.

Hayaski et al. (1972) have shown some diurnal variability in

the activity or ornithine decarboxylase which they related to protein
intake, but lighting conditions were not controlled in their study.
Hernandez et al. (1973) have·shown variability or ornithine
decarboxylase during the estrous cycle of rats, peak levels occurring
during the proestrous phase.
Both plants and bacteria can form 1,4-diaminobutane by an
alternate pathway from arginine.

Agmatine is formed by decarboxylation

of arginine, catalysed by a specific enzyme not found in animals.
Putrescine may be formed from agmatine with the production of urea.
leust in the case of E.coli, ornithine decarboxylase accounts for the
synthesis of

75~98%

of the putrescine (Morris et al., 1970).

Plants,

on the other hand, depend on arginine decarboxylase.
Figure 2 summarizes the pathways of putrescine synthesis.

/

At

19

FIGURE 2. BIOSYNTHESIS OF 1,4·DIAMINOBUTANE

Urea cycle

/
citrulline

arginine

/

-urea

/
ornithine

1,4-diaminobutane

l

agmatine
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CATABOLISM
Diamine oxidase is a copper-containing enzyme purified from hog
kidney.

It catalyses the oxidation of short chain diamines, as well as

histamine, to the corresponding aldehyde.

Gamma-aminobutyraldehyde,

the product of putrescine oxidation, cyclizes to deltal-pyrroline or
it may be further oxidized to gamma-aminobutyric acid (GABA) (Razin, S.
et al., 1959). The functional significance of this pathway for the
formation of the putative neurotransmitter GABA is unknown.
Several bacterial species are capable of converting spermine to
spermidine and beta-alanine.

Spermidine may then be further cleaved

to form another molecule of beta-alanine and GABA (Razin, S. et al.,
1959).
Kakimoto et al. (1969) reported the presence of putreanine
(N-(4-aminobutyl)-3-aminopropionic acid) in the brain of rabbits and
rats.

They felt this compound was unique to the nervous system since

it was not detected elsewhere.

Nakajima (1973) has subsequently de-

tected trace levels in rat liver and has demonstrated that it is a
product of spermidine catabolism.

The significance of its relative

localization to central nervous tissue is unclear.

21
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PUTATIVE FUNCTIONS OF THE POLYAMINES
INTERACTIONS WITH NUCLEIC ACIDS
Low concentrations of polyamines ha.ve a remarkable stabilizing
effect. on DNA.

The melting temperature of DNA is marked'Iy increased

in the presence of concentrations of spermine and spermidine as low as
10-5M (Tabor, H., 1962; Stevens, L., 1970).

The two more likely ways

this is accomplished are that either the amines neutralize the phosphate
groups of.the DNA (reducing the mutual repulsion between ·the strands)
or that they form bridges between the strands.

X-ray diffraction and

electron microscopic studies have favored the latter possibility
(Chevaill:ier, P., 1969; Sutvalsky,M. et al., 1969).

The polyamines do

not alter the conformation of the DNA helix but, when interacting with
RNA, this polynucleotide becomes folded and more compact.
·Polyamines promote the associatinn of ribosomal subunits to form
70S or 80S particles.

Furthermore,. they promote the attachment of

transfer -RNA and messenger -RNA to ribosomes.

Finally, these compounds

have been found in vitro to stimulate the activity of DNA-primed RN.l\
polymerase and possibly also DNA-primed DNA polymerase.

/

Datta et a_l. (1969)
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and Giorgi {1970) have confirmed some of these observations in
preparations of rat cerebral cortex.
In vivo studies
--

of the association of nucleic acids and polyamines

have not been accomplished.

Because of their polycationic nature, the

polyamines redistribute because of their tendency to associate with
subcellular fractionation (Michaelson, I.A. and Smithson, H.R., 1971).
GROWTH AND DEVELOPMENT
In studies of chick embryo, Raina (1963) demonstrated a marked
acceleration of de novo spermine and spermidine synthesis reaching peak
values on the sixteenth day of incubation followed by a sharp decrease.
A second increase in the concentration of these polyamines occurred
between the tenth to fourteenth day after hatching, again followed by
a sharp decline to adult levels.

Similar results were obtained by

Calderera et al. (1965) who demonstrated a close association with
nucleic acid levels.

Manen and Russell (1973) have shown a remarkable

cyclic increase in ornithine decarboxylase and propylamine transferase
activity in the early stages of sea-urchin embryogenesis.

Enzyme

activities increased soon after fertilization, reaching peak levels
within thirty minutes.

Enzyme activities and polyamine levels decreased

just prior to each subsequent cleavage.
shown similar correlations in Drosophila.

Herbst and Dian (1970) have
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Specifically in brain, Calderera et al (1969) have found peak
polyamine levels twelve to fourteen days after fertilization.
then gradually decline

but~

Levels

as in whole embryo and in other isolated

organs, a second peak occurs ten to fourteen days after birth, declining
thereafter to adult levels.
levels.

Parallel changes are seen in nucleic acid

Pearce and Schanberg (1969) have made the interesting

observation that histamine levels undergo similar changes but precede
those of spermidine by 24 to 48 hours.
An association between polyamines and accelerated tissue growth
is apparent in several different models.

In regenerating rat liver,

ornithine decarboxylase activity triples one hour after partial hepatectomy (Russell, D.H. and Snyder, S.H.,
ten times basai ieveis.

1969~).

By four hours levels are

Paraiiei changes occur in RNA leve-ls while

increases in DNA do not occur until 16 or 18 hours later.

Adminis-

tration of actinomycin D or cycloheximide prior to or up to thirty
minutes after the operation prevents the increase in enzyme activity.
Using these dfugs, the

half~life

of newly synthesized ornithine

decarboxylase was found to be 11 minutes , the shortest known for
mammalian enzymes (Russell, D.H. and Snyder, S.H., 1969b; Snyder, S.H.
and Russell, D.H., 1970).

Hypophysectomy also prevents much of the

incr.ease in ornithine decarboxylase and treatment with growth hormone
reverses this effect (Russell, D.H. and Snyder, S.H., l969c).
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CENTRAL NERVOUS SYSTEM
In the nervous system, Kremzer (1970) has found increased
conversion of putrescine to spermidine in peripheral nerve adjacent
to a point of transection, presumably· due to activation of regenerative
processes.

There have been several reports of elevated levels of

polyamines and their associated enzymes in neoplastic tissue including
tumors of the CNS (Kremzer et al., 1970; Snyder, S.H. and Russell, D.H.,
1969b; Ruseell, D.H., 1973).

Levels of urinary polyamines may be

elevated in patients harboring neoplasms (Russell, D.H., et al, 1971;
Russell, D.H., 1973).

Overall however, despite the high concentrations,

there is little evidence concerning the function of polyamines in the
CNS.

ll
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MATERIALS AND METHODS
EXPERIMENTAL ANIMALS
Only male Swiss Albino mice weighing between twenty and thirty
grams were used in the present studies and were obtained from the same
commercial source (Abrams Scientific Animal Farm, Madison, Wisconsin).
They were housed four per cage in standard polyethylene cages
(30 x 18 x 12 em.) with commercial pine sawdust as bedding.

Unless

otherwise indicated, food (Purina Rat Chow) and tap water were
provided ad libitum.
PROGRAMMED LIGHT-DARK CYCLE
All animals were housed in quarters with an automatically-timed

daily cycle of twelve hours of light and twelve hours of darkness.

Light

was provided using commercial Vita-Lite fixtures, emitting a spectrum
of wavelengths similar to that of natural sunlight (Wurtman and Weisel,
1969; McGuire et al., 1973).

The ambient temperature in the quarters

did not vary more than two to three degrees throughout the cycle.
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Extraneous noise was kept to a minimum and the quarters were entered
as seldom as possible during periods of entrainment and experimentation.
All animals were adapted to the above conditions for at least .
three weeks prior to experimentation.

This has been shown to be more

than adequate for the entrainment of most known endogenous rhythms in
rodents (Bruce, 1960; DeCoursey, 1960).
To facilitate various activities in the animal quarters during the
dark phase of the cycle a small lamp emitting a dim red light was used
since this spectrum has the least effect on circadian rhythms
(McGuire et al., 1973).
\

REAGENTS
1. Only distilled-deionized water was used for preparation
of solutions.
2.

Spermidine phosphate was obtained from Sigma Chemical
Co. (St. Louis, Mo.).

Solutions for animal injection

and for bioassay experiments were prepared in 0.9% .
sodium chloride.
3.

Cyproheptadine hydrochloride was kindly supplied by the
Merck, Sharp &Dohme Company (West Point, Pa.).

Because

of its low· solubility in water, fine emulsions were
made in 5% methylcellulose.

Injections were made

intraperitoneally with an 18 gauge needle at 0.1 ml./kg.
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4.

Tripelenamine hydrochloride was kindly supplied by
CIBA (Summit, N.J.).· Solutions were prepared in 0.9%
sodium chloride.

All doses were injected in a volume

of 0.1 ml./kg.
5.

Pentobarbital sodium was prepared in 0.9% saline.

A

fresh solution was prepared prior to each individual
experiment.
6.

Acetycholine hydrochloride was purchased from the
Sigma Chemical Co. (St. Louis, Mo.).

Solutions for

bioassay. were freshly prepared in Tyrode•s solution.
7.

Decaborane (B 10 H14 ) was obtained from Alfa Inorganics,
Inc. (Beverly, Mass.). The powder was dissolved in
corn oil for intraperitoneal injection.

8.

Bio-Rex-63 was purchased from the Bio-Rad Company
(Richmond, California).

9.

0-phthaldialdehyde (OPT) was obtained from Sigma
Chemical Company (St. Louis, Mo.).

10.

Tyrode•s solution was prepared according to the
following formula.

28
REAGENT

CONCENTRATIONS IN GM./LITER

1.

NaCl

8.00

2.

KCl

0.20

3.

CaC1 2

0.20

4. NaHC03
5. MgC1 2 -6H 2o

1.00
0.10

6.

NaH 2Po4 -H 20

0.05

7.

Glucose

1.00

The solution was prepared fresh for each separate preparation.
TOXICITY STUDIES
Intravenous injections of spermidine were given by tail vein.
Intraperitoneal injections of spermidine and other preparations were
given in the usual fashion.
0.1 ml./kg.

All injections were given in a volume of

After the injections, animals were replaced in their

original cages for an observation period of thirty minutes in the case
of the intravenous toxicity study or for 270 minutes in the case of the
intraperitoneal study.
calculate the LD50.

Appropriate dose levels were used in order to
Ide~ical

studies were carried out at regular

intervals (four hours) throughout the light-dark cycle to determine
the diurnal variation in the LD50.

Mortality was attributed to the
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time period when the dose was given.
~iven~

ealculation of the LD50 was

Calculation of the LD50 was made according to the method of

Litchfield and Wilcoxen (1949).

Post-mortem examination was performed

irrunediately after death in several .representative animals and some
simple observations recorded.
PROTECTION FROM THE TOXICITY OF SPERMIDINE
Animals were pretreated with either 0.9% saline, cyproheptadine
or tripelenamine given intraperitoneally thirty minutes prior to the
administration of toxic doses of spermidine.

As in previous studies,

a 270 minute observation period was used in the determination of total
mortality.

In separate experiments, increasing doses of cyproheptadine

and tripelenamine \'/ere employed and a dose response curve constructed.
MOTOR ACTIVITY RHYTHM
Four animals had been entrained in the programmed
cycle for three weeks as described above.

Each was then adapted for

three days to a cage equipped with a photo-cell.

One count was

recorded each time the animal interrupted the photobeam.
water were given

~lib.

light~dark

Food and

The pellets of rat chow and water container

were located at the greatest distance from the photobeam as possible
so as to minimize the recording of simple feeding activity.

/

On the

I

II
I
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fourth day the counts were recorded at regular intervals throughout
the light-dark cycle.

The average number of counts per hour for

all four animals was then plotted versus time of day.

Correlations

were made with the diurnal variation of several different parameters
of interest in this study such as the LD50.
IN VITRO ACTIVITY
Male guinea pigs starved for the preceding 24 hours were killed
at 1000 hours by a blow on the head.

The abdomen was opened and the

distal half of the small intestine to its junction with the cecum was
isolated.

The mesentery was carefully stripped away with fine

ophthalmic scissors.

The lumen was carefully cleared of fecal material

by gently passing Tyrode's solution at 30° C through it using a
standard blunt-tipped pipette.

During preparation the strip of

intestine was maintained in oxygenated Tyrode's solution.
3 em. segment was discarded.

A 2-3 em. segment was then anchored at one

end to a 10 milliliter bath while the other end was
strain gauge.

The distal

No counter balancing weight was used.

connected to a
Bath temperature

was maintained at 30°C with a continuous stream of fine bubbles of
oxygen.

All solutions for injections were maintained in vials cooled

with ice.
A three minute agonist injection cycle was maintained.
was washed thirty seconds after injection of the agonist.
/

The bath

All solutions
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injected had been prepared in Tyrode's solution and thus their pH
was identical to that of the perfusion bath.

After successive

responses to the agonist did not vary by more than two to three millimeters in amplitude, the effect of pretreatment with spermidine prior
to the agonist was evaluated.

The result was expressed as percent

reduction in the amplitude of the average control response to the
agonist.

Injections of agonist alone were subsequently continued until

the response returned to pretreatment levels.

The effect of an

isolated dose of spermidine on the spontaneous activity of the preparation was also determined.
IN VIVO ACTIVITY

Healthy mongrel dogs were anesthetized with intravenous pentothal
sodium.

Tracheostomy was performed on all animals.

A continuous

infusion of 5% dextrose in physiologic saline was maintained.

Respira-

tions were recorded via a string attached to the chest wall and to a
strain gauge.

Electrocardiogram was monitored with standard limb leads.

Blood pressure was monitored via an indwelling catheter in the femoral
artery connected to a pressure transducer.

All injections were made

through an indwelling femoral venous catheter.
on a standard GrassR polygraph.

Responses were recorded
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SLEEPING TIME IN MICE
Sleep was induced with intraperitoneal doses of sodium
pentobarbital.

Onset of sleep was defined as the moment of complete

loss of righting reflex.

Cessation of sleep was marked when the

animal was able to walk 6 inches in any direction (without prodding).
The variation in response to a single dose of pentobarbital was determinted at regular intervals (four hours) throughout the light-dark cycle.
Rectal temperature was monitored during several experiments using a
soft-tipped thermister probe connected to a continuous temperature
monitor {Yellow Springs Instrument Co.).
To determine the effect of injections of spermidine on pentobarbital-induced sleep, groups of animals were pretreated with various
doses of either spermidine or 0.9% saline.

(In addition, a group of

animals was given no pretreatment in order to determine the effect of
the act of intraperitoneal injection alone on subsequent sleeping time.)
Injections of pentobarbital sodium were given at several intervals
after pretreatment.

The optimum pretreatment interval was determined

and used in all subsequent experiments.

Although pretreatment with

physiologic saline did not differ significantly from no pretreatment at
all, this procedure was continued as the control in subsequent studies.
Identical experiments were carried out at four hour intervals
during the light-dark cycle to determine the diurnal fluctuation in the
alteration in pentobarbital-induced sleeping time produced by spermidine.

I
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.

Central levels of histamine were depleted by the use of intraperi-

toneal injections of decaborane as described by Medina et al. (1969).
(This effect was confirmed by fluorimetric assay as described below.).
Sleep was induced with pentobarbital sodium twenty-four hours after the
injection of decaborane and in a group of controls not pretreated with
decaborane.

Some animals were pretreated with both decaborane and

spermidine, 24 hours and 30 minutes re?pectively, prior to the injection
of pentobarbital.

Control animals received injections of corn oil

(for decaborane) or 0.9% saline.

All animals (including controls) were

fasted after injection of the decaborane.

Sleeping time was then

determined as described above.
Central histamine and spermidine levels were determined at 15
minute intervals after the induction of sleep with pentobarbital.
control animals were sacrificed at time zero.

Two

Either pentobarbital or

0.9% saline was then injected into separate groups of animals.

Two

animals were sacrificed from the treated group at 15, 30, 45 &60
minutes after injection.

At 60 minutes two control animals were again

sacrificed along with the two treated animals.
FLUORIMETRIC ASSAY OF SPERMIDINE AND HISTAMINE
Tissue levels of histamine and spermidine were determined according to the method of Michaelson and Coffman (1969) with minor modifications described below.

The reliability and sensitivity of the method
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were evaluated.

Aliquots of standard solutions of both amines were

carri"ed through the entire procedure both alone and in combination
with aliquots of tissue.
Animals were taken from the quarters and immediately killed by
decapitation without anesthesia.
cervi come dull ary junction.
single specimen.

The brain was carefully removed to the

The pons and me dull a were separated as a

The remainder of the brain (mesencephalon, thalamus-

hypothal. and hemispheres) was taken separately.

Specimens were then

placed in an aluminum-foil envelope, which was immersed in liquid
nitrogen.

This was easily accomplished within one to two minutes after

decapitation.

If needed, the entire liver was then removed and treated

in a similar fashion.

All samples were kept frozen until assayed.

tissues were assayed within or\e week of r·emova 1.

PREPARATION OF TISSUES FOR ASSAY
1.

Tissues for assay were homogenized in 0.4N Perchloric
acid containing 1 mg./ml. of EDTA.

The volume of

perchloric acid was equal to four times the weight of
the tissue specimen in grams.
2.

The homogenizing vessel was kept in a container of
ice during the homogenization.

3.

Homogenates were maintained in an ice bucket for ten
minutes before centrifugation.
/

All
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4.

The homogenates were then centrifuged (in their homogenizing vessel) at approximately 2200 rpm for ten
minutes.

For this short interval of spinning the tubes

were cool at the termination of centrifugation.
5.

A four ml. aliquot of the supernatant was then transferred
to a shaker tube containing 0.5 ml. of 5N NaOH, 1.5 gm. of
solid NaCl, 12 ml. of n-butanol.

6.

Tubes were then shaken four times in a vortex mixer for
thirty seconds, resulting in excellent mixing.

7.

Shaker tubes were then centrifuged at 1000 rpm for ten
minutes.

8.

The aqueous phase was then aspirated.

Some solid NaCl

was usually left in the bottom of the tube after this
procedure.
9. The remaining butanol phase was then shaken as above with
5 ml. of a salt-saturated solution of 0. lN NaOH.
10.

Step #7 was repeated.

11. A 10 ml. aliquot of the butanol phase was then transferred
to another shaker tube containing 20 mg. of n-heptane
and 1.5 mg. of 0. lN HCl.
12. The tubes were shaken on the vortex mixer as above.
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13.

Step #7 was repeated.

14.

One ml. of the aqueous phase was diluted in 9 ml. of
0.2M phosphate buffer and adjusted to pH 6.0-6.2 with

lN NaOH.

(3-4 drops from a pasteur pipette were usually

·required)
15.

The entire solution was then applied to the column.
PREPARATION OF THE RESIN

.1.

An adequate volume of resin was hydrated in 4 volumes
of distilled-deionized water.

2.

The mixture was then heated to 80 degrees

(Fah~nheit)

in a water bath for thirty minutes with constant stirring.
3.

The resin was then allowed to settle and the water plus

any slowly settling particles of resin were decanted.
4.

The resin was then washed with 2 volumes of pure ethanol
for ten minutes while stirring constantly.

5. The ethanol was then removed through a Buchner funnel with
tap suction.
6.

The resin was rehydrated in 4 volumes of distilled-deionized
water while stirring constantly for 5 minutes.

7.

The water was decanted along with any slowly settling particles.

8.

Resin was then slurried in a convenient volume of 2N HCl.
One-half the volume of the resin bed was more than adequate.
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9.

The column was formed by transferring the slurry via
pipette to the bed.

A 4 em. bed of resin was appro-

priate for use on a column of 5 millimeter diameter.
ELUTION OF THE RESIN
1.

10 ml. of 2 N HCl were passed through the column.

This

was sufficient to make a strongly acidic eluent.
2.

A sufficient quantity of deionized water vJas ·then passed
through the column until the eluent was no longer acidic.
Thirty ml. of water was usually more than enough.

The

pH of the eluent was followed with long then short range
pH paper.
3.

A sufficient quantity of 1.5M NaOH was then passed through
the column to make the eluent alkaline.

One-half ml. of

the 1.5 M NaOH diluted in 10 ml. of deionized water was
adequate.
4.

Deionized water was again used to remove all traces of alkali.
Twenty ml. were usually required.

5.

1 ml. 2N HCl diluted in 10 ml. deionized water was applied
to make the resin eluent acidic once more.

6.

Deionized water, usually 20 ml., was used to elute all
traces of the acid.
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7.

20-30 ml. of 0.2M buffer were then passed through the
column.

Amines or samples were added at this time by

diluting them in the final 10 ml. aliquot of buffer
being added.

ELUTION OF AMINES
1.

The resin was first eluted with 50 ml. of D2N HN0 .
3
eluate was discarded.

2.

50 ml. O.lN HN0 3 was used to elute the histamine. This
is collected, 1 ml. per tube, in test tubes suitable for

The

development and reading.
3.

40 ml. of 0.2N HN0 3 then eluted the spermidine and this
was collected in 4 a1iljuots of 10 mi. each.

DEVELOPfvlENT
1.

1 ml. of each standard solution were developed along with

a 1 ml. reagent blank consisting of the eluting agent
used for whichever amine was being developed.
2.

Tissue blanks were prepared by adding the phosphoric acid
prior to mixture with OPT.

The final l ml. aliquot

from both the histamine and spermidine eluates were used
for this purpose.
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3.

Formation of the histamine - OPT fluorophore.
a.

0.1 ml. of 4N NaOH 0 mix well.

b.

0.05 ml. of 0.5% OPT- mix well and after
2 minutes add

4.

c.

0.2 ml. of 3.5

H3Po4
Formation of the spermidine fluorophore.

a.

0.3 ml. lN NaOH

b.

0.05 ml. 0.2% OPT- mix well and after 6.5 minutes add

c.

0.15 ml.

2.5~

~

H3P04

FLUORIMETRIC READING
1.

Slit widths in order of sequence from light source to
reading chamber in the Aminco-Bowman Spectra-fluorimeter
\'ere 4-3-2-2.

2.

The 11 HV 11 scale was set at 0.8

3.

A quinine sulfate standard at 2.5 microgm./ml. was read
at an excitation wavelength of 350mu and an emission
wavelength of 450 mu at the above settings using a 30%
scale.

The fluorescence of this solution remained stable

over long periods and was utilized to standardize the
spectrofluorimeter for each experiment.

/
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4.

Tubes containing histamine with the appropriate standards
were read at wavelengths of 350mu and 450mu.

Spermidine

were read at 350mu and 400mu.
SENSITIVITY OF THE METHOD
To assure more complete separation and recovery of histamine
and spermidine the columns were eluted with the appropriate solution
until no trace of the amine in question could be detected in the
eluate. This required volumes of eluent greater than those recommended
in the original procedure of Michaelson and Coffman (1969).

The

recoveries after passing standard amounts of histamine or spermidine
through the entire procedure, alone and in combination with tissue,
are presented in Tables A and B.
STATISTICS

,.,,,
The, paired t -test was employed in calculating levels of
11

si gni fi cance.

11
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QUALITY OF RECOVERY OF HISTAMINE FROM THE METHOD OF MICHAELSON
&

AMT. ADDED

TISSUE*

( rig )

COFH1AN ( 1969)
AMT. RECOV'D.
( ng )

50

49.5,52.5

Whole brain

none

340

Whole brain

50

387

100

98.7,96.1

Liver

none

226

Liver

100

319

200

201.5,196

Whole brain

none

352

Whole brain

200

535

none

none

none

none

300

292,296

Whole brain

none

331

Whole brain

300

620

% RECOVERY
102

94
97.4

93
99.4

91
98

92

*All tissues collected at 1000 hr. from entrained animals
TABLE A

/

.
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QUALITY OF RECOVERY OF SPERMIDINE FROM THE METHOD OF
MICHAELSON & COFFMAN {1969)
AMT. RECOV'D.
( ug )

% RECOVERY

TISSUE*

AMT. ADDED
( ug )

none

25

22.8,25.0

none

117

25

140

92

50

50.5,47. l

97

Whole brain
~Jhole

brain

none
""

__ ,...

96

i ..; "'"' ._

II VIIC:
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Liver

50

92

92

none

100

95.5,98.7

97

none

150

148.5,146

98

Whole brain

none

106

Whole brain

150_

244

L.. '

V '-I

92

*All tissues collected at 1000 hr. from entrained mice
TABLE 8

RESULTS
GENERAL PHARMACOLOGY
Acute intravenous toxicity
Injection of sub-lethal doses of spermidine intravenously
resulted in a consistent sequence of physiologic changes.

Either

immediately after the injection or occasionally before it was even
completed, animals entered a brief period lasting from fifteen to
thirty seconds characterized by i ncr·eased rnotor· activity i nterr·upted

frequently by abrupt jumping high into the air.

These signs

invariably preceded all other signs of toxicity and in their absence
no further signs appeared.

Most fatalities occurred without

progression to further stages and no deaths occurred that were not
preceded by these signs.

For purposes of future discussion, this

period will be referred to as Stage I in the manifestations of
spermidine toxicity.

It was followed immediately by a period

during which the animal remained rather stationary in a crouched
position.

Respirations became hyperpneic and labored with audible
43
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gasping.

Heart rate was regular and rapid.

Vasodilatation was

evident in the vessels of the ears and skin.

Excessive salivation,

lacrimation or defecation were not observed.

Most affected animals

were quite sensitive to the slightest tactile or auditory stimulus,
jumping into the air when touched or with hand-clapping.
animals that attempted to ambulate were clearly ataxic.
henceforth called Stage II, lasted up to fifteen minutes.
further fatalities occurred during this stage.

The few
This period,
All

Stage III was

characterized by a gradual return of spontaneous motor activity
and feeding behavior.

Respiratory and heart rates declined to normal.

Likewise, the piloerection and vasodilatation gradually disappeared.
A more detailed evaluation of neurologic function was possible during
this period.
time.

Animais were unable to balance on a glass rod at this

Initial attempts at walking were characterized by dragging of

the hind legs which were typically in a hyperextended posture with
marked increase in motor tonus.

Even after this resolved, their gait

continued to be quite unsteady with weaving and frequent falls after
which the animal had a great deal of difficulty righting itself.

A

mild hypersensitivity to tactile and auditory stimuli occasionally
persisted into this stage.

No fatalities occurred during Stage III.

Diminishing signs of toxicity could be observed up to two hours after
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injection in animals receiving doses approaching the LD 50,

There

was no observable difference between mice who survived even
potentially lethal doses of spermidine and those who received injections of normal saline.
Post-mortem examination of fatalities revealed only nonspecific gross pathologic changes.

Examination of the heart revealed

a deeply cyanotic myocardium implying significant hypoxia and
hypercarbia.

Excised lungs floated well in

water~

indicating the

absence of a major accumulation of pulmonary edema.

The remainder

of the major organ systems showed no obvious changes.
The LD 50 of spermidine phosphate varied significantly during
the imposed light-dark cycle as shown in Table 1 and, in graphic form,
in Figure 3.

Peak LD 50 ( lowest toxicity ) occurred near the onset

of the dark phase of the cycle.

The lowest LD 50 ( peak toxicity )

was recorded just before the onset of the daylight phase.

The 54.3%

difference between these two points is highly significant (p <.0025).
No alteration in the usual signs of toxicity nor their sequence was
seen during the twenty-four hour cycle despite the change in the LD 50.
The slope of the equation describing the LD 50 function also varied
significantly.

The steepest slope was recorded at the time of peak

toxicity while the opposite was true of the time of least toxicity.
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THE DIURNAL VARIATION OF THE LD 50 OF INTRAVENOUS SPERMIDINE

*p<.0025
n

=5
TABLE 1

/

•

Legend for figure 3 and subsequent similar figures:

abscissa= time in hours.

Black bar represents

period of darkness and open bar
represents period of daylight.

vertical brackets = + 1 S.D.

FIGURE 3. DIURNAL VARIATION OF THE INTRAVENOUS LDSO OF SPERMIDINE
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Intraperitoneal Toxicity
The signs of toxicity after intraperitoneal injection were
similar but not identical to those seen after intravenous injection.
As expected, the signs of toxicity evolved in a more gradual fashion
and persisted for a longer period of time.

Without exception, the

features of Stage I of the intravenous toxicity were not seen after
intraperitoneal injection.

Depending on the dose, the initial

. indications of toxicity were seen as soon as two to three minutes
after injection, or they m1ght be delayed as long as ten minutes.
The first manifestations consisted of signs which corresponded in
essence and sequence to
toxicity.

tho~e

described as Stage II of intravenous

Thus, respiratory distress, tachycardia and vasodilatation

appeared over a five to fifteen minute period.

Hypersensitivity to

envir6nmental stimuli could be demonstrated soon thereafter.

Animals

who attempted to walk were clearly unsteady and had a greatly impaired
ability to right themselves after their frequent falls.

At lower

dose levels, these signs might be quite transient but at doses
approaching the LD 50 they often persisted as long as three to four
hours.

Subsequently all signs subsided excepting the ataxic gait

which was not seen after approximately four and one half hours.
did not seem related to any specific stage of the intraperitoneal

Deaths
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toxicity although very fe\'1 animals died who survived the stage of
respiratory distress.
half hours.

No fatalities occurred after four and one

No observable differences could be found .between treated

and control animals after that

~ime.

As with the intravenous toxicity, a significant diurnal
variation in the intraperitoneal LD 50 was found (the peak LD 50
differed from the trough LD 50 by 52.1%).

A rise in the LD 50 was

recorded near the transition from light to dark as seen with intravenous doses.

In addition, another more variable peak was recorded

just before the onset of light.

The intraperitoneal LD 50 remained

four to five times the value found with the intravenous route.

Again

the slope of the LD 50 function was greatest during periods of peak
toxicity.
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THE DIURNAL VARIATION OF THE LD 50 OF INTRAPERITONEAL

TABLE 2

SPERr~IDINE

fiGURE 4. DIURNAL VJUUATION OF THE INTRAPERITONEAL LD fiO OF SPERMIDINE
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Protect-ion from spermidine toxicity
As seen in table 3, tripelenamine tends to reduce the
mort a1ity from i ntraperitonea 1 doses of spermidine.

Hmvever,

this reached statistical significance only at a dose of 15 mg/kg
of tripelenamine and the 500 mg/kg dose.of spermidine.

Higher

doses of tripelenamine v1ere found to produce signs of toxicity of
themselves (lethargy, ataxia and occasional fatalities).

This

protective effect has been previously reported from this laboratory
(Friedman and Rodichok, 1970).
Cyproheptadine \'Jas considerably more effective in protecting
from spermidine toxicity as seen in Table 4.

At a dose of 0.5 mg/kg

there was a highly significant incr·ease in the LD 50 (reduced toxicity)
as compared to unprotected animals

(p~

.02).

Fatalities in the protect-

ed group showed the usual signs of spermidine toxicity.
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MORTALITY AFTER INTRAPERITONEAL SPERMIDINE.
PROTECTION WITH TRIPELENAMINE.

-

PRE-TREATMENT
TRIPELENM1INE

NONE
DOSE OF SPD

5.0 mg/kg

10 mg/kg

15 mg/kg

11/11

11/11

6/11

5/11

5/11

2/11

1000 mg/kg

11/11

11 /ll

750 mg/kg

9/11

10/11

500 mg/kg

6/11

6/11

1n ;::,n
<JV

L-V

t .........

n,-\ ..

\Ill~/"'~

I

Jii:.O..L.

-rvu~

+ 1 S.D.

= • 05

n

11

=

1

123

TABLE 3

/

;n.. ..i...
;:..

l{)rJ

I

125

-

* p

*

-

*

..
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MORTALITY AFTER INTRAPERITONEAL SPERMIDINE.
PROTECTION WITH CYPROHEPTADINE
PRE-TREATMENT
NONE
0.1 mg/kg

DOSE OF SPD

•

CYPROHEPTADINE
0.25 mg/kg

0.5 mg/kg

1000 mg/kg

11/11

11/11

11/11

9/11

750 mg/kg

9/11

9/11

6/11

2/11

500 mg/kg

6/11

LD 50 (mg/kg
+ 1 S.D.

-

.I

I

468 ± *
125

107

* p <. 02
n

865 + *

'

= 11
TABLE 4

.
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MOTOR ACTIVITY RHYTHM IN MICE
The true circadian nature of motor activity rhythms in rodents
is vvell known (DeCoursey, 1960).

As seen in Figure 5, this rhythm

was v1ell entrained by the environmental conditions used in this study.
Peak activity occurred in anticipation of the onset of darkness and
gradually receded as daylight approached.

An inconsistent peak

often occurs at the onset of light as in this study.

The difference

betv1een peak and trough values is significant { p <. .001 ).

The

secondary peak at the onset of daylight did not reach statistical
significance in this study.
Figure 6 depects in graphic form the correlation between the
motor activity rhythm and the rhythm for intravenous spermidine
toxicity.

Both peak LD 50 and peak motor activity just anticipate the

onset of darkness.

Similarly, a less significant peak can be seen

in both rhythms at the onset of daylight.
The correspondence between the rhythm of intraperitoneal
spermidine toxicity and motor activity is less remarkable as seen in
Figure 7.

Nevertheless, significant peaks occur in the toxicity rhythm

at approximately the same times as in the activity rhythm.

Fig::..zre5. Diurnal variation of the motor activii·y of rnke
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IN VITRO ACTIVITY
Spermidine had no effect.on the acetylcholine-induced
contraction of guinea-pig ileum 0hen

i~jected

after the agonist.

A consistent reduction in the a~plitude of contractile response was
seen however when spermidine was injected ten seconds prior to the
At a final concentration of 0.8ui•1 spermidine resulted

acetylcholine.
in

appro~imately

a 20% reduction in amplitude.

l.6uM.and 3.2uM, a 50% reduction was seen.
produced no greater effect.
had no effect.

At concentrations of

Higher concentrations

Control injections of Tyrode's solution

When injected more than ten seconds prior to the

agonist, spermidine had no effect.
tractions. induced with barium.

Spermidine did not affect con-

Figure 8 shows representative examples

of the effect of spermidine injected ten seconds before acetylcholine.
At increased sensitivity (.02mv/cm) the effect of spermidine
on the spontaneous activity of the guinea-pig ileum can be seen
(Figure 9).

At a final concentration of 1.6uM there is a significant

reduction of the amplitude of the spontaneous contractions although
the frequency is unchanged.
muscle tone occurs.
effect.

A small depression of the baseline

Control injections of Tyrode's solution had no

Fi ,ure 8. The effect of s ermidine on the acet• lcholine-i::9;.ced contraction of guinea pig ilc"Jm
Responses 1-3 represent consecutive
control injections of Ach (4.5tlgjml) .

r

O.BpM

.
\
_Jj

r
=
rJ J --r~r

The fourth was preceded ( 10 srx:. )
b y an ·111JeC
· t·1011 or sp..:-rml'-•i
o.
· ...:·na
~ ... ·t. '·
1~e
...... '-'L
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concentration indicated.
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0

Figure 9. The effect

10 sec.

of spermidine on the spontaneous <:•Gtivity of guinea pig iisum
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IN VIVO EFFECTS OF SPERMIDINE IN DOGS
Injection of 0.75 - 1.00 mg/kg dose of spermidine intravenously was sufficient to produce a marked cardio-pulmonary response.
A prompt reduction in the mean blood pressure and a rise in the
pulse pressure were associated with hyperpnea and tachycardia.
These parameters showed a gradual recovery over the following one
to two minutes (Figure 10).

Injections of histamine at a dose of

5 ug/kg produced a very similar response (Figure 10).

Following

the first effective dose of spermidine, subsequent injections were
of little or no significant effect.
Intravenous injection of 200 mg/kg spermidine caused
instantaneous loss of detectable blood pressure and irreversible
apnea.

Cardiac electrical activity was detectable for a short time

thereafter, showing marked ST-T segment depression and T-wave
inversion.

FIGURE 10. RESPONSE TO INTRAVENOUS SPERr"l!D!NE (a)8.: H!STAMH~E{b)IN THE DOG
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BARBITURATE-INDUCED
1.

SLEEPI~G

TIME IN MICE

The effect of pre-treatment with spermidine on the duration of
barbiturate-induced sleeping time.
Pre-treatment with doses of spermidine significantly
prolonged sleep after sodium pentobarbital.

This effect was

clearly maximal when the spermidine was given thirty minutes
prior to sleep induction.

A suggestion of a similar result was

seen with doses given sixty minutes before while no change
occurred with pre-treatment at 120 minutes.

A dose of 300 mg/kg

was approximately twice as effective as 150 mg/kg.

It is of

interest to note the mild alteration in duration produced by
sham pre-treatment with physiologic saline.

Though not

statistically significant, all subsequent studies utilize this
form of control for reasons to be discussed

later~

Table 5

summarizes these data.
2.

Diurnal variability of the duration of barbiturate-induced
sleeping time and the effect of pre-tteatment with spermidine
thereon,
The duration of barbiturate-induced sleep in mice varied
significantly during the programmed twenty-four hour light-dark
·cycle (Table 6 and Figure 11).

Peak duration occurred in

anticipation of the onset of daylight while a trough was seen
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just prior to the onset of the dark phase.

The difference

between these values is significant ( p < .001}.

As seen

in Figure 11, the duration of sleep was inversely related
to motor activity.
The prolongation of sleep produced by pre-treatment
with sperm·idine was likevtise time-dependent (Table 6).

The

diurnal curve maintains the same phase relationships as with
barbiturate alone (Figure 11), peak sleeping time occurring
just priot' to the onset of daylight.

Spermidine seemed to

abolish the trough appearing just prior to the onset of
darkness, the point at which the greatest relative increase
over control vvas seen (Table 6).
..
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THE EFFECT OF PRETREATMENT WITH SPERMIDINE ON BARBITURATE-INDUCED SLEEP

l...--

DURATION OF SLEEP (Minutes +
- l S.D.)
Pre-Treatment

1

Minutes prior to
barbiturate i nj.

none

saline

Spd-l50mg/kg

Spd-300mg/kg

30

41± 3

45+ 6

-

57± 3*

71± 2**

60

41± 3

45± 6

48+- 2

53:!; 3

120

41± 3

45+ 6

38:!: 3

41± 2

* p < .05 (versus saline control)
**p < .001 (versus saline control)
n

=5
TABLE 5
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FIGURE 11. DIURNAL VARIATION OF SLEEP AFTER PENTOBARBITAL(o---e) INCREASED BY SPERMIDINE{.6.--A)

100

80

/~\\

~

/ \
+
''.t----+------/

//

/

.-.
•
.5
E

-1000

\

\

.

60

"""c:
0
:.=

~
0

..,

800

~

<"

\\

600~
n
0

c

;::,

e:> 40

~

400 en

-o

"'0

..,Cb

0..

::r

(!)
<1,)

c;;

c

0

20

200

~~~~~~~------~----------·~--~~~~~
.......
12
18
24 ..~~~~.a
6

TIMI:: (edt)

~
.._..

68
DIURNAL VARIABILITY IN THE DURATION OF SLEEP AFTER PENTOBARBITAL
ALTERED BY PRETREATMENT WITH SPERM I DINE

,.......
Duration of sleep (minutes ± l S.D.)

% increase

Pre-Treatment
Time

saline

Spd-300mg/kg

0200

54± 4.6

71± 2.6

32 ( p < • 01)

0600

*
63± 7.5 **

76± 7.2***

38 ( p < . 05)

1000

44± 5.2*

60± 2.2***

36 ( p < • 02)

1300

43± 2.9

62± 6.7

45 ( p < • 05)

1900

29± 3.0**

67+ 4.9

135( p <. 001)

2200

39± 5.4

71± 1.0

86 ( p <.001)

.
*

p <,05

** p

<. 001

*** p " . 001
n=

5
TABLE 6
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3.

Interaction between central biogenic

a~ine

depletion, sleeping

time and spermidine.
Decaborane has been shown to deplete the levels of
several biogenic amines in the CNS, maximally at a point twentyfour hours after injection (von Euler and Lishajko, 1965;
Merritt and Sulkowski, 1967; Medina et al., 1969).
was made to duplicate all of these studies.

I

I'

No attempt

The effect of

decaborane on central histamine levels was confirmed.

In

addition, a significant reduction of central spermidine was
demonstrated as seen in Table 7.
Pre-treatment with decaborane markedly prolonged the
duration of sleep after pentobarbital.

Whereas a dose of

pentobarbita1 of 30 mg/kg. is insufficient to produce sleep in
control animals.

I

I

l

I
I

I
I
I

A dose of 60 mg/kg was followed by only

42 ~ 3 minutes of sleep in the control group.

At this dose of

pentobarbital, of twelve animals pre-treated with decaborane
six died after periods of deep sleep and six slept for periods
exceeding 120 minutes but survived.

Spermidine alone did not

produce sleep in pre-treated animals nor did the usual signs of
toxicity seem altered.

Pretreatment with both decaborane and

spermidine significantly prolonged the duration of sleep as
compared to pre-treatment with spermidine alone but this combination was less effective than decaborane alone.
summarized in Table 8.

These data are
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REDUCTION OF WHOLE BRAIN HISTAMINE AND SPERMIDINE LEVELS
HJENTY-FOUR HOURS AFTER DECABORANE

,.-Whole brain histamine
( ng I gm : 1 S • D• )

I
I

Whole brain spermidine
(ug/gm ± 1 S.D.)

I

I

I

'
I

I

Control

318

± 9*

109

± 7**

Decaborane

168

± 12*

82

± 8**

I--

''

''

I

I
I
I
t

*

p < • 001

**p < .05
n = 3

TABLE 7
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THE EFFECT OF PRETREATMENT WITH DECABORANE &/or

SPER~H DINE

ON THE DURATION OF SLEEP AFTER PENTOBARBITAL
,--

Pretreatment
,.....-

'

'\

Pentoba rbita 1

sleep duration
(min.± l S.D.)

Db

Spd

30mg/kg

60mg/kg

-

-

+

-

0

-

-

-

+

42 +
-3

-

+

+

-

15 + 2*

-

+

-

+

60 ± 2

+

+

-

70 ± 5*

+

-

-

+

6 deaths &
6 slept 120 min.

+

+

-

-

0

+

+

+

-

41

+

+

-

+

12/12 deaths

±4

Db = Decaborane, 15mg/kg intraperitoneally 24 hours prior to
sleep-induction
Spd =Spermidine, 300 mg/kg i.p. 30 min. prior to sleep-induction
* p < .001 (versus control injection of corresponding dose of
pentobarbita 1 alone)

TABLE 8

•
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4.

The time course of histamine and spermidine levels during sleep
induced by pentobarbital.
Table 9 demonstrates the reduction in central histamine
levels during barbiturate-induced sleep. A maximum reduction
of 22% was seen forty-five minutes after the onset of sleep.
Significant reduction of midbrain and caudate histamine levels
by pentobarbital has been reported previously in rats (Friedman,
A.H. and Walker,C.A.,1969). Little change occurred in the levels
of spermidine during sleep , the maximum reduction being 11% at
forty-five minutes (Table 9).
DIURNAL VARIATION OF

HISTAt~INE

AND SPERI>1IDINE LEVELS

IN WHOLE BRAIN,MYELENCEPHALON AND LIVER.
HISTAMINE
Levels of histamine were highest in

~~~/hole

brain 11 (mesencephalon,

hypothalamus-thalamus and hemispheres). Significant levels were also
detected in the medulla-pons and liver. During the programmed lightdark cycle peak levels occurred in all three tissues just prior to
the onset of the dark phase. Lowest levels \vere reached within four
hours after the onset of darkness (Table 10 and Figure 12).

73

TIME COURSE OF v!HOLE BRAIN HISTAMINE AND SPERMIDINE
DURING BARBITURATE-INDUCED SLEEP
r-

minutes after injection
control

r-

\!lhole brain histamine
(ng I gm)

45

control

30

202

197

173 202

225

48.5

42.5

40.0 43.0

48.0

*

*

222

60

15

Whole brain spermidine
45.5

(ug I gm)

n =2
*p

= .01

- four control animals (226 :!: 6. 1 nglgm) compared to
....

. '
four· an1n1als col1ecteu
ctt 3u & 4o mHiu-ces
~

TABLE 9

/

I "" ,.. ,-

~ 1~:::>

!

~

. ng;gm) .

JLt

\
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SPERMIDINE
Levels of spermidine were higher in the medulla-pons than in
the whole brain. Relatively low concentrations were detected in the
liver. Levels in all three tissues showed a diurnal variability
similar to that of histamine. Peaks occurred just before the onset
of darkness while lowest levels were found at the onset of tf1e daylight phase. In the case of the medulla-pons and whole brain ,
higher levels were still present four hours after the onset of
darkness (Table 10 and Figure 13).

-"---DIURNAL VARIABILITY IN THE LEVELS OF HISTAMINE AND SPERMIDINE IN w"HOLE BRAIN, MYELENCEPHALON & LIVER
Time

.
o

Whole brain

0800
210 - 20

1300
242 "!: 11

Myelencephalon

136 +
-

148

90 + 31

Liver

*p
**

n =
0

.
'

tJ)

(!)

...-l

•M +I

•M

S

e~

(!)

bO

tJ)

'-'

p,

;::l

47

±

4

Myelencephalon

80 +
-

8

Liver

16 +
-

3

*p

+

4

201 - 76

+

186 -: 27

221 -

4

2300

*

186 +
- 4

*';'(

165 +
- 58

*

*
*
*

57 -:

9

110

92-:

10

155

7

49

+

26 -

+ 6

93

*'

82 -:

18

"!:

< .001
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FIGURE 12.DIURNAL VARIABILITY OF HISTAMINE LEVELS
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I
t
l

DISCUSS ION

'
'

'

Few studies of the in' vivo acute toxicity of S!Jermidine have
been reported.

Intravenous injections of both spermine and spermidine

have been reported to cause transient hypotension and respiratory
distress (Tabor, C.W., and Rosenthal,

S.M.~ 1956).

In a more.recent

I

study, Shaw (1972) reported sedation, respirator_y distress and ataxia

~

after parenteral injections of both spermine and spermidine.

l

doses were attended by clonic convulsions as well.

Lethal

In the present

study intravenous injections of spermidine in mice were foi1ov1ed
immediately by a brief period of hyperactivity (Stage I).

Stage II

of the intravenous toxicity and the first signs of intraperitoneal
toxicity were marked by severe respiratory distress, tachycardia and
cutaneous vasodilatation.

Deaths occurred in ei.ther Stage I (intra-

venous) or Stage II and were often preceded by agonal myoclonic seizure
activity.

Survivors of these stages showed a variable period

(Stage III) of ataxia, motor retardation and hypersensitivity to noise
and tactile stimuli.

In sub-lethal ·doses little effect was seen on

rectal.temperature.

Although a direct action of spermidine cannot be

excluded, these effects are quite similar to those seen after
injections of histamine (Douglas, W.W., 1968; Kahlson~ G. and
Rosengren, E., 1965).

This is supported by the simi lRrity in response

to intravenous injection of histamine and spermidine in dogs

78
demonstrated here.

Although this response was easily distinguished from

that of serotonin in the dog, the effects of this amine vary with

I
t

different species and are often quite similar to those of histamine.
Cyproheptadine has been shown to have both potent anti-histaminic and
anti~serotonergic

l

1972).

I

properties (Stone, C.A. et al, 1961; Van Reizen, H.,

The fact that this compound offered greater protection from

the toxicity of spermidine than did tripelenamine, an anti-histamine
which has no significant anti-serotonergic activity, suggests that
both histamine and serotonin may be released by spermidine.

Neither

spermidine nor spermine pass the blood brain barrier (Snyder, S.H. et al.,
1973) and thus a primary central site of action can be dismissed.
Platelets and masts cells, storage sites for both histamine and

I

serotonin, are possible sites of action·for spermidine.

Other

polyamines such as the polymer 11 48/80 11 are potent releasers of
biogenic amines from these sources (Rothschild, A.M., 1970).

In the

present study, dogs showed a marked tachyphylaxis to spermidine injections.

This could very well be due to depletion of histamine and

serotonin stores after the first effective doses and would therefore
lend support to the notion that spermidine acts by releasing these
amines.

Tachyphylaxis is characteristic of the pharmacology of both

histamine and serotonin.
Effective and lethal doses of spermidine were considerably
higher with intraperitoneal as compared to intravenous administration.

t

I

.·
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This might be explained on the basis of incomplete and/or slow
absorption through the peritoneum, resulting in lower and less
effective blood levels.

An additional factor however might be that

spermidine is inactivated during absorption by this route.

Diamine

oxidase catalyses the oxidation of both spermidine and histamine and is
present in significant quantities along the gastrointestinal tract
(Kim, K.S., et al., 1969).

This enzyme may have oxidized a

significant proportion of intraperitoneal doses of spermidine.

Diurnal

variation in the activity of this enzyme has not been studied and,if
significant, could further complicate studies using this route.
Diurnal variability in the LD50 of spermidine has not been
studied previously and must be considered in

future experimentation.

The intravenous LD50 in mice repm'ted by Shaw (1972) (78 mg/kg) is
somewhat lower than values reported here but a lighting regimen
was not utilized. Factors underlying such a variation are likely to
be multiple.

The significant fluctuation in spermidine levels shown

here may in part reflect changes in the activity of catabolic enzymes.
The abrupt change in the slope of the intravenous LDSO curve seen at
the point of highest toxicity is significant.

Steepening of the

curve must indicate either an alteration of the turnover of spermidine
or heightened receptor sensitivity (Nelson, W., and Halberg, F., 1973).
The correlation of lowest toxicity with peak endogenous ·levels of
spermidine may point to a decrease in catabolism.

The decrease in

80
spermidine toxicity occurs at a time when endogenous histamine levels are

l

highest and serotonin levels are low.

!

well as other biogenic amines often correlate with increased release

I

Endogenous levels of these as
I

and catabolism (Kahlson, C. and Rosengren, E., 1968; Hery, F. et al.,
1972; Mandell, A.J. et al., 1974).

The functional significance of such

a correlation is therefore unclear without further study.

Since no

change in the manifestations of toxicity was seen within the twenty-four
hour cycle, a change in mode of action is unlikely.
The
here.

~vitro

activity of spermidine was not extensively studied

Polyamines have been previously shown to antagonize the con-

traction of guinea pig ileum induced by a variety of agents including
acetylcholine, histamine, 5-HT and nicotine
et al, 1968).

(Der~eis,

L., 1967; Onodera, K.,

DeMeis and DePaula (1967) and Nagai et al.(l969) have

both reported a specific inhibition of magnesium-activated ATP-ase of
myofibrils, myosin B and native actomyosin by polyamines.

A similar

action on vascular smooth muscle might explain the hypotension and
cutaneous vasodilatation seen after spermidine injection but would not
account for many of the other manifestations.
The basis for the well-established hypnotic effect of
. barbiturates is not known.

The duration of sleep after appropriate

doses is dependent on many factors.

Reduction of ambient room tempera-

ture below 30°C prolongs the duration of barbiturate-induced sleep
(Raventos, J., 1938).

Several drugs known to potentiate the hypnotic
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I

effect of barbiturates owe their action to their ability to induce
hypcthermia (Lessin, A.W., and Parkes, M.W., 1957).

The

environmental temperature was therefore kept constant during this study.
Although lethal doses of spermidine were associated with agonal hypothermia, no significant change in rectal temperature was seen with
doses used to evaluate the effect of spermidine on pentobarbital-induced
sleeping time.

At the dosage utilized in the present study (60 mg/kg)

pentobarbital-induced sleep was attended by a decline of rectal temperature of approximately soc.
spermidine.

This was unaffected by pre-treatment with

Nevertheless, pretreatment with spermidine prolonged

the duration of sleep after pentobarbital.

Since spermidine does not

pass the blood-brain barrier, the basis for this effect must be peripheral.
This would not exclude the possibility of the r2lease of a centrally
active compound.

Both serotonin and histamine have been shown to

P,rolong drug-induced sleeping time and, as noted above, could have been
released by spermidine (Fastier, F.N., et al., 1957).

Polyamines might

also conceivably inhibit the degradation of barbiturates by the liver,
thus elevating CNS concentrations of the drug and prolonging sleeping
time.

As noted above,this would be consistent with the association of

polyamines with active synthesis, particularly in the liver.
A diurnal rhythm in the duration of barbiturate-induced sleep
as shown in the present study, has been reported previously (Davis, W.M.,
1962; Lindsay H.A. and Kullman, V.S., 1966; Scheving, L.E. et al, 1968b).

r
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In most nocturnal species peak duration occurs during darkness and
corresponds to the period of peak motor activity and highest body
temperatures.

This may in part be related to the diurnal rhythm of

hepatic drug metabolism (Radzialowski, F.M. and Bousquet, W.F., 1968;
Jori, A., et al., 1971).

However, recent studies have implicated a

change in receptor sensitivity to barbiturates as well (Nelson, W.
and Halberg, F., 1973).
Decaborane reduces central levels of norephinephrine and serotonin
as well as histamine.

(Von Euler, U.S. and Lishajko, F., 1965; Merritt,

J.H. and Sulkowski, T.S., 1967; Schayer, R.W. and Reilly, M.A., 1971).
Its effect on PST seen in this study certainly suggests that the
effect of barbiturates on sleep involves one or more of these biogenic
amines.

In contrast to the rat (Friedman, A.H. and Walker, C.A., 1969)

pentobarbital caused a small but significant reduction in central histamine
levels, perhaps the basis of its synergism with decaborane.

Even if

spermidine releases peripheral stores of histamine or serotonin
neither of these biogenic amines enter the CNS in effective concentrations.
However, spermidJne alone also prolonged PST.

This effect was significantly

increased during the transition from light to dark.

This is the period

of least toxicity of spermidine, suggesting that the action on PST is
mediated differently, perhaps by competition for enzymes in the liver
metabolizing the pentobarbital.

J
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Daily fluctuation in the levels of many of the biogenic amines
is well established {Scheving, L.A. et al, l968a; Friedman, A.H.
and Walker, C.A., 1969; Piepho, R.W. and Friedman, A.H., 1971; Saita, Y.,
1971; Walker, C.A. et al., 1971).

Peak levels of histamine in rat

brain have been found early in the dark phase of the cycle (Friedman, A.H.,
and Walker, C.A., 1969; Garbarg, M. et al., 1974).

In the present

study of the mouse, peak levels of histamine in brain and liver just
anticipated the dark phase.

The association of elevation of histamine

levels with the period of greatest motor activity is in keeping with
recent interest in the activating effect of histamine on the CNS
(Monnier, M. et al., 1970; Taylor, K.M. and Snyder, S.H., 1971).
Depletion of histamine levels by decaborane correlated with increased
sleeping time.

Stress caused by cold or restraint is associated with

increased turnover of histamine (Taylor, K.M. and Snyder, S.H., 1972).
Intraventricular injections of histamine have a definite awakening
effect (Monnier, M. et al., 1970).
Significant diurnal variability in polyamine levels has not
been reported previously.
of histamine.

The phase of this rhythm was the same as that

Recent studies have renewed interest in a possible

interaction between histamine and spermidine.

As discussed above,
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both are associated with periods of raPid growth, particularly during
embryogenesis.

During these periods, a significant proportion of

histamine is localized within the nucleus as is spermidine (Kuhar, M.
et al., 1971; Young, A.B. et al., 1971; Snyder, S.H., and Kuhar, t1.,
1972).

The parallel reduction of histamine and spermidine levels

during barbiturate-induced sleep shown here supports this association.
On the other hand, a significant fraction of histamine in adult neural
tissue is associated with synaptic elements and has some features of a
true neurotransmitter (Snyder, S.H. and Kuhar, M., 1972).

Polyamines

are not known to be associated with this fraction.
The studies reported here are clearly preliminary and incomplete.
In studying the acute toxicity of spermidine a picture consistent with
a release of histamine and serotonin was seen.

The prolongation of

barbiturate-induced sleeping time after pretreatment with spermidine may
be mediated differently.

The diurnal fluctuation in spermidine levels

and toxicity has not been previously established and must be considered
in future studies.

Further investigation into the neuropharmacology

of the polyamines seems warranted.

SU~1MARY

Some pharmacologic properties of the polyamine spermidine have
been studied.

Toxicity in mice after intravenous injection consisted

of acute respiratory distress and myoclonic seizures followed by
a period of lethargy, ataxia and irritability.

Intraperitoneal doses

produced a similar sequence of signs evolving over a longer period.
Significant diurnal variability of the LD 50 was found with a peak
for both the i.v. and i.p. routes occurring during the transition from
light to dark in a programmed 24 hour cycle of twelve hours of light
and twelve hours of darkness.

This peak corresponded to the peak of

the daily motor activity rhythm.

Pretreatment with either cypro-

heptadine or tripelenamine significantly reduced the LD 50 of
spermidine.

Intravenous doses of spermidine in dogs caused acute

hypotension, tachycardia and tachypnea and were associated with
marked tachyphylaxis.
similar picture.

Injections of histamine produced a very

Neither the diurnal fluctuation of the LD 50 of

spermidine nor its alteration by tripelenamine and cyproheptadine have
been reported previously.
Pretreatment with spermidine reduced the amplitude of acetylcholine-induced contraction of guinea pig ileum.

The amplitude of

the intrinsic rhythmic activity was also transiently diminished after
spermidine.
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The di urn a1 variability in barbiturate-induced sleeping time was
confirmed) peak dur::ition occurring late in the dark phase of the
cycle. Pretreatment Vtith spet'midine significantly prolonged sleeping
time. This effect

1·1as

variable in magnitude during the 24 hour cycle ,

peak prolongation occurring at the transition from

l~ght

to dark

~

the time period of peak LD 50 of spermidine and highest levels of
endogenous spermidine and histamine.
A diurnal rhythm of endogenous levels of spermdine and histamine
was established in whole brain, myelencephalon and liver. Highest
levels of both amines occurred just prior to the onset of darkness •

r
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